3D Structure of the “Gateway” to the Liver Could Enable Treatments To Fight Hepatitis
- on May 11, 2022
Though it is an essential gateway to the liver, NTCP had not been well described before now. Na+-taurocholate co-transporting polypeptide (NTCP) is a protein located exclusively in the membrane of liver cells that enables recycling of bile acid molecules. It is also the cellular receptor of human hepatitis B and D viruses (HBV/HDV). A better understanding of NTCP could enable the development of treatments specifically designed for the liver, and to fight HBV and HDV infection.
NTCP is a difficult protein to study. It weighs only 38 kilodaltons (kDa), whereas cryo-electron microscopy, the technology used to study this type of molecule, only works for molecules weighing more than 50 kDA. The challenge was therefore to “enlarge” and stabilize it.
To do this, teams from French and Belgian laboratories developed and tested a collection of antibody fragments targeting NTCP. The 3D structures of the resulting complexes were determined using cryo-electron microscopy, and different antibody fragments stabilized and revealed several forms of NTCP.
The team of scientists was able to describe two essential NTCP conformations: one in which the protein opens a large membrane pore to bile salts, to which HBV and HDV can bind, and a second, ‘closed’ conformation, that prevents recognition by the viruses.
The first, ‘open’ conformation is very surprising, as no other known molecular transporter forms such a ‘wide open’ pore. In turn, the second conformation could help in finding antiviral molecules that prevent HBV and HDV infection. The team of researchers intends to continue its work to fully elucidate the functioning of NTCP.
Reference: “Structural basis of sodium-dependent bile salt uptake into the liver” 11 May 2022, Nature.
- A kilodalton is an atomic mass unit equal to 1,000 daltons. One dalton is one-twelfth the mass of a carbon-12 atom (the mass of a hydrogen atom, approximately).
- The study was conducted by teams at the MPF Laboratory (Microbiologie fondamentale et pathogénicité) (CNRS/University of Bordeaux), the Membrane Protein Mechanisms Unit at the Institut Pasteur, and the VIB-VUB Center for Structural Biology. This study was supported by the ANRS Emerging Infectious Diseases Program, among others.